2Michael Rybak,Ben Lomaestro,John C,et al.Therapentic monitoring of vancomycin in adult patients:a consensus review of the American Society of Health-System Pharmacists,the Infectious Diseases Society of America,and the Society of Infectious Diseases Pharmacists.Am J Health-Syst Pharm,2009,66:82-98.
6Catherine Liu,Arnold Bayer,Sara E,et al.Clinical practice guidelines by the infectious diseases society of America for the treatment of MRSA infections in adults and children.Clinical Infectious Diseases,2011,52:285-292.
7Sakoulas G,Gold HS,Cohen RA,et al.Effects of prolonged vancomycin administration on methicillin-resistant staphy-lococcus aureus(MRSA) in a patient with recurrent bacteraemia.Antimicrob Chemother,2005,57(4):699-704.
3Larsson A,Flodin M,Hansson LO,et al.Patient selection has a strong impact on cystatin C and modification of diet in renal disease(MDRD) estimated glomerular filtration rate[J].Clin Biochem,2008,41(16-17):1355-1361.
5Knight EL,Verhave JC,Spiegelman D,et al.Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement[J].Kidney Int,2004,65(4):1416-1421.
6Jonsson AS,Flodin M,Hansson LO,et al.Estimated glomerular filtration rate(eGFR CystC) from serum cystatin C shows strong agreement with iohexol clearance in patients with low GFR[J].Scand J Clin Lab Invest,2007,67(8):801-809.
7Hojs R,Bevc S,Ekart R,et al.Serum cystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patients with chronic kidney disease[J].Clin Nephrol,2008,70(1):10-17.
8Tanaka A,Suemaru K,Otsuka T,et al.Hoek's formula,a cystatin C-based prediction formula for determining the glomerular filtration rate,is the most effective method for original adjusting the dosage of vancomycin[J].Int J Clin Pharmacol Ther,2007,45(11):592-597.
9Zappitelli M,Parvex P,Joseph L,et al.Derivation and validation of cystatin C-based prediction equations for GFR in children[J].Am J Kidney Dis,2006,48(2):221-230.
10Macisaac RJ,Tsalamandris C,Thomas MC,et al.Estimating glomerular filtration rate in diabetes:a comparison of cystatin C and creatinine-based methods[J].Diabetologia,2006,49(7):1686-1689.
3Rybak M,Lomaestro B,Rotschafer JC,et al.Therapeutic monitoring of vancomycin in adult patients:a consensus review of the American Society of Health-System Pharmacists,the Infectious Diseases Society of America,and the Society of Infectious Diseases Pharmacists[J].Am J Health Syst Pharm,2009,66(1):82-98.
4Jeffres MN,Isakow W,Doherty JA,et al.A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia[J].Clin Ther,2007,29(6):1107-1115.
5Bosso JA,Nappi J,Rudisill C,et al.Relationship between vancomycin trough concentrations and nephrotoxicity:a prospective multicenter trial[J].Antimicrob Agents Chemother,2011,55(12):5475-5479.
